The goal was approximately, not exactly, 2400 patients. They have been at 2418 patients for a few months now, consistent with their previous news release that they have completed enrollment. So unless an SSRA occurs AND the results of the SSRA recommend increasing enrollment AND Resverlogix takes the advice to increase enrollment, then enrollment is complete at 2418. What is quite interesting is that both the AAIC poster for the cognitive sub study and the ERA-EDTA poster for the CKD sub study indicate patient dosing range between 6 and 36 months. This suggests that enrollment is done and dosing will be complete around mid November (36 months after first dosing). All just my take on available info.
BearDownAZÂ
